Evolvable platform for designing cancer treatment strategies using nanoparticles

Project Details

Description

EVO-NANO develops an integrated platform for the artificial evolution and validation of novel strategies for treatment of cancer using nanoparticles (NPs). We expect our proposed framework to provide a full pipeline for the development of effective NP-based therapies that are safe, have optimal bio-distribution and delivery characteristics and can be personalised to specific patients and health risks.
AcronymEVO-NANO
StatusFinished
Effective start/end date01/10/1831/03/22

Collaborative partners

  • Åbo Akademi University
  • University of the West of England (Project partner)
  • Vall d'Hebron Research Institute (Project partner)
  • University of Novi Sad (Project partner) (lead)
  • University of Bristol (Project partner)
  • IMDEA Nanoscience (Project partner)
  • ProChimia Surfaces

Funding

  • EU H2020: €268,861.25

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being